Department of Health

Victorian Medical Research Acceleration Fund

Applications are now open for round 7 grants.

Medical research sector
Closed

The Victorian Medical Research Acceleration Fund (the VMRAF) was first launched by the Victorian Government in 2017. The VMRAF is designed to capitalise on Victoria’s competitive advantages in research, increase the efficiency of the Victorian health system and improve health outcomes for Victorians.

The VMRAF provides $3 million per annum to support and accelerate health and medical research by providing one-off grants to successful applicants. 113 projects have received funding through the 6 previous rounds of the VMRAF, providing $20.4 million to the Victorian health and medical research sector.

Round 7 of the VMRAF will deliver $3 million in one-off grants to support early-stage research (Tier 1) and ‘fast-track’ the translation of research into health and economic outcomes (Tier 2).

Round 7 of the VMRAF will run alongside Round 3 of the mRNA Victoria Research Acceleration FundExternal Link , administered by the Department of Jobs, Skills, Industry and Regions (DJSIR).

Round 7 of the VMRAF will be administered by the Department of Health (the department).

Applicants can only apply for one program (the VMRAF or the mRNA Victoria Research Acceleration Fund).

Program objectives

Round 7 of the VMRAF will include one $3 million Foundation Stream, which consists of 2 tiers of funding:

Tier 1 – Early-stage research

Support innovative early-stage health and medical research that brings health and economic benefits to Victoria.

Facilitate collaboration between health services, medical research institutes, universities and industry that maximises innovation and improves the likelihood that the funded project will be successfully translated.

Up to $100,000 (GST exclusive) is available per project.

Tier 2 – Research translation

Provide direct funding to 'fast-track' the translation of health and medical research into health and economic outcomes.

Facilitate collaboration between health services, medical research institutes, universities, and industry to become investment-ready and stimulate translational activities.

Up to $500,000 (GST exclusive) is available per project.

Broader objectives

The VMRAF aims to facilitate collaboration between health services, medical research institutes, universities and industry that maximises innovation, supports talent retention, improves the likelihood that the funded projects will be successful, and increases the likelihood that the outputs of health and medical research generate health outcomes for all Victorians.

These program objectives align with the four pillars of the Health and Medical Research Strategy: 2022-2032 – Talent, Collaborate, Big Ideas and Generating Outcomes.

Outcomes

The expected outcomes of the VMRAF are:

  • medical research is moved to proof-of-concept stage faster and the benefits of health and medical research are delivered to the public faster (Tier 1)
  • research collaborations improve the targeting of early-stage research to likely end-users (Tier 1)
  • research collaborations support the translation of research into more commercially attractive products (Tier 2).

Promoting gender equality

Under the Gender Equality Act 2020 (Vic), the department must promote gender equality. The VMRAF seeks to promote gender equality by encouraging the participation and inclusion of women in applicant project teams.

The VMRAF allocates a proportion of the assessment criteria weighting in favour of applicants with project teams that include at least 50 per cent of members who identify as women or applicants with project teams that are led by a Chief Investigator (CI) who identifies as a woman.

  1. Grants open

    20 October

    Applications will remain open for 6 weeks.
  2. Grants close

    01 December

    Applications must be submitted by 4pm on the closing date. No late applications will be accepted.
  3. Successful applicants notified

    March 2024

  4. Letters of offer issued

    March 2024 – April 2024

    Letters of offer issued to successful applicants followed by, subject to acceptance by relevant applicants, issuing draft agreements.
  5. Agreements executed

    May 2024

    Earliest date by which applicants can expect agreements to be executed.

Guidelines

  • The VMRAF offers a total of $3 million (GST exclusive) of grants:

    • Tier 1: Early-stage

    Early-stage innovative research proposals for projects that demonstrate potential for translation at a later stage

    Up to $100,000 (GST exclusive)

    • Tier 2: Fast track

    Fast track translation of research to products or practices into clinical or health practice

    Up to $500,000 (GST exclusive)

  • Collaborative Partner requirement

    To apply for the VMRAF, an applicant is required to collaborate with at least one other organisation (Collaborative Partner). Ideally the Collaborative Partner is an end user that can support the translation and/or commercialisation of research.

    Applications must identify the Collaborative Partner and must attach relevant proof of collaboration as an attachment to their application in accordance with the requirements set out in the ‘Documentation and Information Requirements’ at section 9 of these guidelines.

    The application and supporting evidence should demonstrate how the applicant and Collaborative Partner organisations will work together under the collaborative partner arrangements to maximise research impact, innovation, and overall quality of research, and how this will lead to effective translation and/or commercialisation of research.

    Collaborative Partner eligibility

    Applicants and their Collaborative Partners must be entirely separate entities. They must not be owned by the same parent company, share governance, or have common directors.

    In the application, applicants are required to declare there are no existing governance relationships between themselves and the nominated Collaborative Partner, including that they:

    • are not subsidiaries or related bodies corporate within the meaning of the Corporations Act 2001 (Cth) and
    • do not share common directors, officers, or senior managers.
  • Grant funding under the VMRAF will be provided on the basis that applicants provide 1:1 matched cash co-contribution (Co-Contribution Funding).

    Co-Contribution Funding can be provided by the lead organisation, the collaborative partner, or another source.

    Applicants must provide the department with evidence to the department’s satisfaction of Co-Contribution Funding in their application, which must meet the requirements of section 9 of these guidelines.

    Applicants must provide the department with evidence, to the department’s satisfaction, that any required Co-Contribution Funding has been used for the purposes of the Applicant’s project.

    In-kind contributions cannot form part of an applicant’s required Co-Contribution Funding.

    Grant funding from other State or Commonwealth Government programs awarded to the Applicant specifically for the purposes of supporting a project to be submitted under this VMRAF cannot form part of the Applicant’s required Co-Contribution Funding. General Applicant organisational funding from State or Commonwealth Government sources may form part of the required Co-Contribution Funding.

    Examples of co-contribution amounts

    Tier 1

    If the total project cost is $320,000 (excluding GST), the maximum Grant contribution will be $100,000 (excluding GST). The remaining $220,000 (excluding GST) must be covered by the Applicant.

    If the total project cost is $82,000 (excluding GST), the Grant will cover up to $41,000 (excluding GST). The remaining $41,000 (excluding GST) must be covered by the Applicant.

    Tier 2

    If the total project cost is $1.2 million (excluding GST), the maximum Grant contribution will be $500,000 (excluding GST). The remaining $700,000 (excluding GST) must be covered by the Applicant.

    If the total project cost is $780,000 (excluding GST), the Grant will cover up to $390,000 (excluding GST). The remaining $390,000 (excluding GST) must be covered by the Applicant.

  • General project eligibility

    Projects should meet a current need or gap in a field of medical research. This could be, but is not limited to:

    • innovative approaches to treatment and/or prevention of disease
    • development of new pharmaceuticals, diagnostics or devices or
    • studies into current health practices to guide future research targeted at solving weaknesses in current practice.

    Eligibility of projects will be determined at the sole discretion of the department.

    Applicants are only able to submit a project to one tier of the VMRAF, and the same project will not be eligible to be submitted to the other tier of the VMRAF or Round Three of the mRNA Victoria Research Acceleration Fund.

    Eligible projects under the two tiers of the VMRAF should be as follows (to be used as a guide only):

    Tier 1
    • Early-stage innovative health and medical research projects, including discovery research, clinical research and/or health service research.
    Tier 2
    • Health and medical research projects that can demonstrate a clear pathway to translation and can secure development and commercialisation opportunities.

    Eligible project expenditure

    Eligible expenditure items are:

    • regulatory and intellectual property fees and charges associated with registering domestic or international patents or other intellectual property enforcement expenses
    • equipment, consumables and services required for the research activity as outlined in the project description provided that such equipment, consumable or service is not listed as an ineligible expense in section 6.3 and
    • staffing costs that relate solely to either:
      • new employees or
      • the expansion of hours for current part-time employees, provided these employees are working on the funded projects or
      • the extension of contracts for staff whose contracts would otherwise end within the period of the agreement.

    Ineligible activities/expenditure

    Grant funding received from the VMRAF must not support the following expenditure items:

    • usual operational expenditure, including existing staff costs, communications, travel entertainment, vehicles, accommodation, and office computing equipment
    • routine replacement or minor upgrade of plant and equipment
    • printing, stationery, postage, and bank charges
    • basic and routine professional services including legal and accounting fees
    • any amount paid on account of goods and services tax
    • costs related to preparing the grant application, preparing any project reports and preparing any project variation requests
    • building routine websites, sales and promotional activities, marketing or communications campaigns
    • retrospective funding of projects that have already:
      • been completed prior to receiving an offer of grant funding under this VMRAF round; or
      • commenced prior to receiving an offer of grant funding under this VMRAF round, except in circumstances where the application of the grant funding can be demonstrated to effect a change of scope or acceleration of a project commenced prior to any funding approval and
    • any other expenditure as determined by the department in its sole and absolute discretion.

    Project budget

    Applicants are required to submit a project budget summary detailing how the VMRAF grant funds and the applicant’s required Co-Contribution Funding will be spent.

    Grant funds provided to the applicant under the VMRAF need to meet the eligible project expense criteria outlined in section 6.2 of these guidelines. Co-Contribution Funding is not subject to eligibility criteria. However, the applicant must demonstrate that all Co-Contribution Funding will be applied to the applicant’s project.

    Where the eligibility of an expense included in the project budget is uncertain, the department may seek further information from an applicant.

    Program timeline

    To assist applicants, the department is targeting the following indicative timeline for the VMRAF:

    To assist applicants, the department is targeting the following indicative timeline for the VMRAF:

    • March 2024 - Notification provided to successful applicants.
    • March 2024 - April 2024 - Letters of offer issued to successful applicants followed by, subject to acceptance by relevant applicants, the issuing of draft agreements.
    • May 2024 - Earliest date by which applicants can expect agreements to be executed.

    The timeline is subject to change at the sole discretion of the department. applicants are not to rely on this indicative timeline and the department accepts no liability in relation to any consequences attributable to reliance on this indicative timeline.

    Projects funded by a grant under the VMRAF must be commenced by the applicant following execution by the applicant and the department of an agreement and completed within two years of the commencement date recorded in that grant agreement.

    Projects initiated or completed beyond the timeframe of this VMRAF round may still be eligible if the proposed activities supported by funding are completed within two years in accordance with the conditions of the applicant’s agreement.

  • This is a competitive program and successful applications will be required to rate highly against the assessment criteria compared to other eligible applications. Eligible applications will be assessed by an expert panel external to the department. The panel will sign confidentiality agreements and a Conflict of Interest declaration.

    Assessment criteria

    Eligible applications will be assessed on how well they meet the assessment criteria as outlined below with reference to the relevant stream and tier of the program applied for by the applicant. All supplementary attachments and information provided as part of the application will be taken into consideration during the assessment and scoring process.

    Assessment criteria

    Consideration

    Weighting

    The quality of the research project proposal and the extent to which it aligns with the program objectives as set out in section 1.2 and 1.3

    Tier 1:

    • demonstrates how this grant will support innovative early-stage research. The application should address how the project delivers value through innovative knowledge creation, knowledge transfer and/or knowledge application
    • the health and/or clinical need for this research has been clearly articulated and
    • how well the partnership collaboration will support the project to:
      • maximise innovation
      • improve the quality of research and
      • increase the likelihood that this research will translate successfully into clinical practice.

    Tier 2:

    • articulates how the grant will ‘fast-track’ the translation of research into health and economic outcomes
    • the health and/or clinical need for this research has been clearly articulated and
    • · clearly articulates how the partnership will collaborate to:
      • strengthen the research activity
      • progress the research to the investment-ready stage and
      • stimulate translational activities.

    30 per cent

    The extent to which the proposal will meet the outcomes of the program as set out in section 1.4

    Tier 1:

    • the value of the expected outcome/s of the research project to Victoria, Victorians and to Victoria’s health and medical research capabilities has been well defined and
    • potential future pathways to translation and/or commercialisation have been articulated.

    Tier 2:

    • the value of the expected outcome/s of the research proposal to Victoria, Victorians and to Victoria's health and medical research capabilities has been well defined
    • articulates how this grant will accelerate the speed at which the project outcomes will be delivered to the public and
    • clearly articulates how the research will translate effectively into practice or products.

    30 per cent

    Demonstrated project feasibility and delivery

    For both Tier 1 and Tier 2:

    • clear implementation strategy and resourcing to be able to deliver the project
    • appropriate organisational commitment to the project
    • commitment from Collaboration Partner/s demonstrating support from industry, philanthropy, health service, education or research institute
    • Co-Contribution Funding has been identified and committed to the project
    • identified appropriate technical resources, skills and capabilities, including where appropriate a strong track record of key personnel
    • a well-developed and suitable budget for the project
    • evidence of agreed and suitable environment in which to undertake the proposed research and
    • identified project risks and mitigation strategies.

    25 per cent

    Ability to deliver within the timeframe and need for government support

    For both Tier 1 and Tier 2:

    • demonstrates the ability to deliver the project within the set timeframe and realise its outcomes and
    • considers whether the project would proceed without government support due to considerations such as timing, resourcing and/or level of risk impacting project initiation.

    10 per cent

    Promotion of gender equality

    For both Tier 1 and Tier 2:

    • demonstrates that at the time of project commencement the project team will consist of at least 50 per cent members who identify as women.

    2.5 per cent

    • demonstrates that the project is led by a Chief Investigator who identifies as a woman.

    2.5 per cent

    Due diligence assessments

    Where required, applicants are subject to a risk assessment which verifies business details provided with the Australian Business Register, Australian Securities and Investment Commission, Australian Charities and Not-for-profits Commissioner, Consumer Affairs Victoria and/or other applicable regulator.

    Any of the following circumstances may be taken into consideration in any decision whether to award a grant:

    • any adverse findings by a regulator regarding an applicant
    • if an applicant is placed under external or voluntary administration or is subject to receivership
    • there is a petition to wind up or deregister the applicant
    • if an Applicant is or becomes deregistered or unregistered in respect of its registration regulatory body (including cancellation or lapse in registration) and
    • whether the applicant has failed to meet key contractual obligations for previous grant agreements with the State. Note: as appropriate, delays due to COVID-19 restrictions and responses will be taken into consideration at the department’s discretion.
    • For Applicants that don’t hold an existing service agreement with the department, and are eligible for a Service Agreement, the department may request the organisation’s last two financial statements or annual reports for the purposes of financial accountability requirements.[1]

    [1] Organisations funded through the departments Modelling and Payment Systems (MAPS) are exempt from this requirement

  • Applicants must undertake the following steps to apply:

    1. Carefully read these guidelines and ensure they meet all eligibility requirements.
    2. Compile all necessary supporting documents and complete all required attestations as detailed in the ‘Documentation and Information Requirements’ section of these guidelines.
    3. Prepare an application and apply online via the Business Victoria application portalExternal Link .
    4. Await email confirmation of application submission. Please check spam/junk mail if confirmation email cannot be seen in your inbox.

    Open and close dates

    Applications will open on Friday 20 October 2023 and remain open for 6 weeks

    Applications will close on Friday 1 December 2023 at 4pm.

    Applications must be submitted by 4pm on the closing date. No late applications will be accepted.

    All applicants will be advised via email of the outcome of their application approximately 12 weeks after the closing date.

Reviewed 20 October 2023

Was this page helpful?